Clinical Trial Update: Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

View source ↗

Summary

This clinical trial update reports the completion and posting of results for an observational study evaluating Lumigan (bimatoprost) 0.01% for primary open-angl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Lumigan (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Status: COMPLETED | Results posted: 2013-09-20